Metoclopramide G.L. Pharma

Metoclopramide, the active ingredient in Metoclopramide G.L. Pharma, is a dopamine antagonist presented as an injectable solution for intravenous use. It is employed to control nausea and vomiting and to enhance gastrointestinal motility in patients with gastroparesis or migraine‑associated nausea.

GNH USA supplies Metoclopramide G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures reliable delivery, regulatory compliance and support where required, meeting the needs of healthcare providers across Europe, Asia, Africa and the Americas.

Metoclopramide acts on dopaminergic pathways to reduce nausea and improve gastric motility.

- Nausea and vomiting: provides rapid relief of acute, postoperative or chemotherapy‑induced nausea. - Gastroparesis: accelerates gastric emptying and alleviates related dyspeptic symptoms. - Migraine‑associated nausea: reduces nausea accompanying migraine attacks. - Post‑operative nausea and vomiting: helps prevent and treat nausea after surgical procedures. - Chemotherapy‑induced nausea and vomiting: improves patient tolerance to anti‑cancer regimens.

Metoclopramide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness or fatigue - Restlessness or akathisia - Diarrhea or abdominal cramping - Headache or dizziness - Dry mouth - Mild extrapyramidal movements

Serious or Rare Side Effects: - Tardive dyskinesia with long‑term use - Neuroleptic malignant syndrome - Severe depression or suicidal thoughts - Seizures - Anaphylactic or severe allergic reactions - Hyperprolactinemia with galactorrhea

Use of Metoclopramide requires careful assessment of patient‑specific factors and monitoring for known risks.

- Renal impairment: dose adjustment may be required. - Hepatic impairment: use with caution and monitor liver function. - History of extrapyramidal disorders: avoid or limit use. - Pregnancy: category B1; weigh maternal benefit against potential fetal risk. - Concomitant CNS depressants: monitor for enhanced sedation. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metoclopramide can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other dopamine antagonists (antipsychotics): additive extrapyramidal effects. - Strong CNS depressants (benzodiazepines, opioids): increased sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Anticholinergics: may reduce pro‑kinetic effect. - SSRIs or other serotonergic agents: potential serotonin syndrome. - Digoxin: possible increase in serum levels. - Alcohol: may enhance central nervous system depression.